NEW

This week produced convergent evidence on community-based acute care — strong RCT evidence for Hospital-at-Home preserving physical function and a critical gap in virtual ward risk stratification — alongside an urgent OPAT prescribing safety signal and the first confirmed timeline for a national Frailty and Dementia Modern Service Framework.

A retrospective cohort study of 2,533 remotely monitored virtual ward admissions found that the National Early Warning Score (NEWS2) had poor predictive accuracy for hospital readmission in this setting, with an area under the curve of 0.55 — raising governance questions for risk stratification in community-based acute care.

A single-centre randomised clinical trial (n=111) found that a hybrid Hospital-at-Home model significantly increased early physical activity — patients took 1,763 more steps in the first 24 hours than inpatients — with higher patient satisfaction and no signal of excess harm.

A systematic review and meta-analysis of 11 studies (n=2,568) found ceftriaxone associated with significantly increased 30-day mortality (OR 3.33, 95% CI 2.17–5.10) compared with antistaphylococcal penicillins or cefazolin for MSSA bloodstream infections. A concurrent cost analysis of CADD-pump-based OPAT demonstrated 88% cost savings versus inpatient care, providing the delivery mechanism for safer beta-lactam alternatives.

A national NHS England-approved analysis of over 970,000 decedent records found that specialist palliative care contacts are recorded in GP records for only 4–5% of patients on average, a rate insufficient to function as a service quality indicator.

A pragmatic NIHR-funded randomised controlled trial across 15 NHS sites found no significant improvement in physical health-related quality of life from a 24-week therapist-delivered home exercise programme for older adults with mild, moderate or severe frailty following hospital discharge.

NHS England published its first monthly corridor care dataset on 11 June 2026, recording an average of 2,940 patients per day receiving care in clinically inappropriate settings in May 2026.

This week produced three simultaneous developments: the HERO trial's clarification of community rehabilitation evidence, the first NHS England corridor care dataset, and a convergence of palliative and end-of-life care findings at the threshold of a national policy decision.

A retrospective cohort of 2,533 NHS virtual ward admissions found NEWS2 achieved an AUC of 0.55 for predicting unplanned hospital readmission across all pathways — a performance that does not support its use as a decisional threshold in remotely monitored populations, including frailty and OPAT.

A meta-analysis of eleven studies found ceftriaxone use for MSSA bloodstream infections associated with OR 3.33 for 30-day mortality compared with anti-staphylococcal penicillins or cefazolin.